Brad Knott stock trades
- Most recent buys: CMPO (Jan 14, 2025).
- Largest disclosed buy: $1,001 - $15,000 of CMPO on Jan 14, 2025.
Price changes use the closing price on each trade date, not the price actually paid, and ignore dividends. Filings report amounts only as ranges, so these figures show direction, not anyone's actual profit.
Brad Knott reported 3 transactions in 1 disclosure filing with the House Clerk for 2025–2026: 2 purchases and 1 sale across 2 stocks, with trade dates from Jan 10, 2025 to Jan 14, 2025. The most-traded stock is CMPO (2 trades). The median gap between trade date and filing date is 46 days, and 2 trades were reported more than 45 days after it happened.
Brad Knott currently serves in the US House of Representatives for NC's 13th congressional district (NC-13) as a Republican. This profile is generated from 1 periodic transaction report in the House Clerk's public disclosure index.
- 3
- 2025–2026
- 2 / 1
- $17K – $80K
- sum of reported ranges
- #114
- of 177 filers by row count
Republican · NC-13 · Latest filing 2025-02-25. Ranges are the filed brackets; no midpoint estimates or portfolio value are inferred.
Would copying these trades beat the S&P 500?Most-traded tickers
The 12 most-reported tickers, ranked by transaction count. Tickers with three or more rows for this member link to a dedicated page; others link to the all-Congress ticker page or the company profile.
| Ticker | Rows | Buys | Sells | Last trade |
|---|---|---|---|---|
| CMPO CompoSecure, Inc. - Class A Common Stock | 2 | 2 | 0 | 2025-01-14 |
| ORMP Oramed Pharmaceuticals Inc. - Common Stock | 1 | 0 | 1 | 2025-01-10 |
Disclosure profile
- Periodic reports parsed
- 1
- Distinct tickers
- 2
- First / last trade
- 2025-01-10 → 2025-01-14
- Median filing lag
- 46 days
- Rows filed after 45 days
- 2
- Reported owner
- Self 3
How long disclosure took
Days from trade date to filing date for 3 rows. The STOCK Act allows 30 days from notification and no more than 45 days from the trade. A late row is a timing fact, not evidence of wrongdoing.
- 0–15 days
- 0
- 16–30 days
- 0
- 31–45 days
- 1
- Over 45 days
- 2
- Median / longest
- 46d / 46d
Source documents
1 House Clerk periodic transaction report, newest first. Each link opens the official filing.
- #20027846Filed 2025-02-25 · 3 rows
What Brad Knott's filings don’t tell you
A disclosure row records a trade date, an amount bracket, and who owned the asset. It does not say why the trade was made, whether the position is still held, or anything about the business behind the ticker: revenue trends, margins, balance-sheet risk, or valuation. Those answers are in company filings, not congressional ones.
To work through a company yourself, use our stock research checklist. Members get the full version of that work: one sourced investment call a month, with the numbers and the risks that would change the view.
Members-only research
What members are reading this month
- NVIDIA’s growth has a financing bill
Sales up about 18% on the prior quarter, receivables up about 55%, supply commitments at $279 billion. What NVIDIA’s financing bill means for the price you pay.
- Citadel bought the AI fire sale. The seller had run out of time.
Up 439% in the first half, down about 67% in July: how an AI hedge fund ended up selling a roughly $16 billion stock book to Citadel at a discount.
The thesis, the numbers behind it, and what would break it. Full access is $39 a month.
Read the full researchAll verified transactions
Parsed from official House Clerk periodic transaction reports for 2025 and 2026. Sort any column, filter by type or reported owner, and open the filing date to read the source filing. Amounts are the ranges reported on the filing.
| Type | Owner | ||||
|---|---|---|---|---|---|
CompoSecure, Inc. - Class A Common Stock CMPO | Purchase | Self | $1,001 - $15,000 | 2025-02-25 #20027846 | |
CompoSecure, Inc. - Class A Common Stock CMPO | Purchase | Self | $1,001 - $15,000 | 2025-02-25 #20027846 | |
Oramed Pharmaceuticals Inc. - Common Stock ORMP | Sale | Self | $15,001 - $50,000 | 2025-02-25 #20027846 |
Under the STOCK Act, lawmakers must disclose reportable securities transactions publicly. A filing is a delayed, range-based disclosure, not a real-time trading signal or proof of motive.
Most active filers in Congress
Explore the disclosure data
Brad Knott: frequently asked questions
How many stock trades has Brad Knott disclosed?
The House Clerk periodic transaction reports covering 2025 and 2026 contain 3 reportable transactions for Brad Knott: 2 purchases, 1 sales, across 2 distinct tickers. Rows may belong to the member, a spouse, a dependent, or a joint account.
What does Brad Knott trade most?
CMPO (CompoSecure, Inc. - Class A Common Stock) appears most often, with 2 disclosed transactions (2 purchases, 0 sales). The most-traded table on this page lists every ticker with a verified row.
How much money is involved in Brad Knott's disclosed trades?
Filings report amounts as ranges, not exact values. Summing the low and high ends of every range gives a disclosed total between $17K – $80K across 3 transactions. Yield Theory does not convert ranges to midpoints or estimate portfolio value or returns.
Does Brad Knott file trades on time?
The STOCK Act requires disclosure within 45 days of a transaction. Across Brad Knott's trades the median gap between trade date and filing date is 46 days, and 2 trades were reported more than 45 days after it happened. Late filing is a disclosure-timing fact, not evidence of wrongdoing.
Is it legal for members of Congress to trade stocks?
Yes. Members may trade individual stocks but the 2012 STOCK Act requires public disclosure, usually within 45 days, and bans trading on material non-public information. Proposals to ban individual stock ownership by members recur regularly.
Yield Theory is not affiliated with, endorsed by, or connected to any elected official. Information is compiled from public STOCK Act disclosures filed with the US House Clerk for 2025 and 2026 and from the public congress-legislators dataset. Image-only filings are not parsed, so this is not a complete lifetime portfolio; filings can be amended and are reported in ranges. This page is educational and is not investment advice.
Don’t copy the filing. Read the thesis.
Brad Knott disclosures are delayed, ranged, and often a spouse. Members get the monthly call that treats those rows as one input, then names catalysts, risks, and what would change the view. $39/month or $249/year.
Members-only research
$39/mo or $249/yr · cancel future renewals anytime · sources included